文献速递重症综合管理与镇静镇痛

入住ICU前使用抗炎药物对重症后抑郁和焦虑风险无影响

No Impact of Preadmission Anti-Inflammatory Drug Use on Risk of Depression and Anxiety After Critical Illness.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论倾向评分匹配的丹麦全国队列显示,入住ICU前使用他汀类、非甾体抗炎药或糖皮质激素与重症后3年新发抑郁和焦虑风险无关。

该研究为倾向评分匹配的基于人群的队列研究,纳入2005至2013年丹麦所有ICU中接受机械通气的48,207例成人患者。暴露为入住ICU前单用或联用他汀类、非甾体抗炎药或糖皮质激素,结局为重症后3年新发精神科诊断的抑郁或焦虑或抗抑郁/抗焦虑药物处方。匹配后他汀类用户6,088对、非甾体抗炎药用户2,886对、糖皮质激素用户1,440对、联合用药用户1,743对。各药物组3年抑郁和焦虑累积发病率分别为他汀类18.0%(95%CI 17.0-19.0%)、非甾体抗炎药21.3%(95%CI 19.8-22.9%)、糖皮质激素17.4%(95%CI 15.4-19.5%)、联合用药19.0%(95%CI 16.3-20.2%),非用户与用户相似。与未使用相比,风险比分别为他汀类1.04(95%CI 0.96-1.13)、非甾体抗炎药1.00(95%CI 0.90-1.11)、糖皮质激素0.97(95%CI 0.82-1.14)、联合用药1.05(95%CI 0.90-1.21),均未达统计学显著,亚组和敏感性分析结果一致。

要点

  • 在48,207例ICU机械通气成人中,入住ICU前使用他汀类、非甾体抗炎药、糖皮质激素或联合用药均未改变重症后3年抑郁和焦虑风险。
  • 他汀类用户3年抑郁和焦虑累积发病率为18.0%(95%CI 17.0-19.0%),非甾体抗炎药用户为21.3%(95%CI 19.8-22.9%)。
  • 糖皮质激素用户3年累积发病率为17.4%(95%CI 15.4-19.5%),联合用药用户为19.0%(95%CI 16.3-20.2%),非用户与用户相似。
  • 与未使用相比,他汀类风险比1.04(95%CI 0.96-1.13),非甾体抗炎药1.00(95%CI 0.90-1.11),糖皮质激素0.97(95%CI 0.82-1.14),联合用药1.05(95%CI 0.90-1.21)。
  • 结果在性别、年龄、入住ICU前疾病、入住类型等亚组及抑郁和焦虑分别分析的敏感性分析中一致。

适用人群与场景

  • 2005至2013年丹麦所有ICU中接受机械通气的成人患者,共48,207例。

研究设计与关键结果

  • 研究设计为倾向评分匹配的基于人群的队列研究,纳入48,207例ICU机械通气成人,暴露为入住ICU前单用或联用他汀类、非甾体抗炎药或糖皮质激素,结局为重症后3年新发精神科诊断的抑郁或焦虑或抗抑郁/抗焦虑药物处方。
  • 倾向评分匹配后他汀类用户6,088对、非甾体抗炎药用户2,886对、糖皮质激素用户1,440对、联合用药用户1,743对。
  • 3年抑郁和焦虑累积发病率:他汀类用户18.0%(95%CI 17.0-19.0%),非甾体抗炎药用户21.3%(95%CI 19.8-22.9%),糖皮质激素用户17.4%(95%CI 15.4-19.5%),联合用药用户19.0%(95%CI 16.3-20.2%),非用户与用户相似。
  • 与未使用相比,3年抑郁和焦虑风险比:他汀类1.04(95%CI 0.96-1.13),非甾体抗炎药1.00(95%CI 0.90-1.11),糖皮质激素0.97(95%CI 0.82-1.14),联合用药1.05(95%CI 0.90-1.21)。
  • 结果在性别、年龄、入住ICU前疾病、入住类型等亚组及抑郁和焦虑分别分析的敏感性分析中一致。

证据类型、等级与局限

  • 证据类型:倾向评分匹配的基于人群的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于ICU机械通气成人,入住ICU前使用他汀类、非甾体抗炎药、糖皮质激素或联合用药不改变重症后3年抑郁和焦虑风险,原文结论为未改变风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Risk of depression and anxiety is elevated after intensive care. Drugs with anti-inflammatory properties may have antidepressant and anxiolytic effects. The aim of this study was to investigate the association between preadmission use of drugs with anti-inflammatory effects and risk of new-onset depression and anxiety among adult patients admitted to an ICU.

DESIGN: Propensity score-matched, population-based cohort study.

SETTING: All ICUs in Denmark from 2005 to 2013.

PATIENTS: Adults receiving mechanical ventilation in an ICU.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A total of 48,207 ICU patients were included. Exposures were preadmission single-agent or combined use of statins, nonsteroidal anti-inflammatory drugs, or glucocorticoids. Outcomes were cumulative incidence (risk) and risk ratio of new-onset psychiatrist-diagnosed depression or anxiety or prescriptions for antidepressants or anxiolytics. Propensity score matching yielded 6,088 statin user pairs, 2,886 nonsteroidal anti-inflammatory drug user pairs, 1,440 glucocorticoid user pairs, and 1,743 combination drug user pairs. The cumulative incidence of anxiety and depression during the 3 years following intensive care was 18.0% (95% CI, 17.0-19.0%) for statin users, 21.3% (95% CI, 19.8-22.9%) for nonsteroidal anti-inflammatory drug users, 17.4% (95% CI, 15.4-19.5%) for glucocorticoid users, and 19.0% (95% CI, 16.3-20.2%) for combination users. The cumulative incidence was similar in nonusers compared with users in all drug groups. The risk ratio of depression and anxiety 3 years after admission to ICU was 1.04 (95% CI, 0.96-1.13) for statin users, 1.00 (95% CI, 0.90-1.11) for nonsteroidal anti-inflammatory drug users, 0.97 (95% CI, 0.82-1.14) for glucocorticoid users, and 1.05 (95% CI, 0.90-1.21) for combination users, compared with nonusers. Results were consistent across subgroups (gender, age, preadmission diseases, type of admission) and sensitivity analyses (depression and anxiety separately).

CONCLUSIONS: Preadmission use of statins, nonsteroidal anti-inflammatory drugs, glucocorticoids, or combinations did not alter the risk of depression and anxiety after critical illness.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Medici CR, Gradus JL, Pedersen L, et al. No Impact of Preadmission Anti-Inflammatory Drug Use on Risk of Depression and Anxiety After Critical Illness. Crit Care Med. 2017. PMID: 28920927. doi:10.1097/CCM.0000000000002571

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。